Production (Stage)
Sanara MedTech Inc.
SMTI
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -10.92% | 21.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.92% | 21.38% | |||
| Cost of Revenue | -18.42% | 12.91% | |||
| Gross Profit | -10.21% | 22.24% | |||
| SG&A Expenses | -2.07% | 17.94% | |||
| Depreciation & Amortization | 2.07% | -0.21% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.75% | 20.15% | |||
| Operating Income | -53.89% | -0.34% | |||
| Income Before Tax | -107.42% | 41.01% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -107.42% | 41.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -99.88% | 540.32% | |||
| Net Income | -129.25% | 46.16% | |||
| EBIT | -53.89% | -0.34% | |||
| EBITDA | -282.39% | -2.75% | |||
| EPS Basic | -128.29% | 46.26% | |||
| Normalized Basic EPS | -45.62% | -6.56% | |||
| EPS Diluted | -128.29% | 46.26% | |||
| Normalized Diluted EPS | -45.62% | -6.56% | |||
| Average Basic Shares Outstanding | 0.45% | 0.17% | |||
| Average Diluted Shares Outstanding | 0.45% | 0.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||